ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, today announced the second close of its Series D financing round, adding $13 million and increasing ...
Insulin patch pump maker ViCentra announced today that it closed a $13 million extension to its Series D financing round.
Demacia is finally here to startoff 2026! Here is a look at the many changes coming to League of Legends in the LoL Patch ...